Renal TLR7 expression is associated with renal injury in female mouse model of systemic lupus erythematosus
Authors: Chaudhari Sarika , D'Souza Bradley M. , Morales Jessica Y. , Lima Caroline , Young‐Stubbs Cassandra M. , Ma Rong , Mathis Keisa W. 
Published: May 2022

BackgroundSystemic lupus erythematosus (SLE) is an autoimmune disorder associated with exaggerated immune activation, autoantibody production, and immune complex formation. SLE patients are predominantly women of reproductive age that often present with end organ damage, specifically in the kidneys, and hypertension. This detrimental sequelae is likely due to deposition of the immune complexes and the resulting inflammation, but the exact mechanisms are unknown. It is known however that immune complexes activate toll like receptors (TLRs) on immune cells and TLR7 particularly is known to promote the development and acceleration of the pathogenesis of SLE. Therefore, we hypothesized that renal TLR7 drives the renal injury and hypertension in female SLE mice.MethodsDouble‐stranded DNA (dsDNA) autoantibodies, a hallmark of SLE, and albuminuria, a marker of renal injury, were monitored at 30 and 35 weeks of age in female and male SLE (NZBWF1) and control (NZW) mice. Glomerular filtration rate (GFR) was measured by sinistrin clearance and renal TLR7 and tumor necrosis factor (TNF)‐α expression were measured via Western blot to assess renal function and renal inflammation at the end of 35 weeks. Mean arterial pressure was also measured in conscious mice at 35 weeks of age using indwelling arterial catheters.ResultsAt 30 weeks, female SLE mice had elevated plasma dsDNA autoantibodies compared to female controls (4.6e5 ± 1.3e5 vs 8.9e4 ± 3.3e4; n=3‐5; all p<0.05), male SLE mice (6.3e4 ± 2.7e4 U/mL), and male controls (4.8e4 ± 9.3e3). At 30 weeks, 32% (7 out of 22) of female SLE mice had albuminuria versus 5% (1 out of 22) of female controls, 5% (1 out of 20) of male SLE, and no male controls. At 35 weeks, 63% (10 out of 16) of female SLE mice had albuminuria versus 5% (1 out of 22) of female controls, 5% (1 out of 19) of male SLE, and no male controls. GFR was lower in female SLE mice compared to males at this same time point (865 ± 77 vs. 1066 ±60 μL/min/100 g body weight; p=0.029). Female SLE mice expressed a significantly higher renal cortical expression of TLR7 (3.9e5 ± 8.0e4 intensity units) than both female control (7.5e4 ± 2.6e3 intensity units; p < 0.001) and male SLE mice (7.0e4 ± 1.5e4 intensity units; p < 0.001). Renal cortical expression of TNF‐α, a downstream effector of TLR7, was increased in female SLE mice (1.3e6 ± 3.7e5 intensity units) when compared to both female control mice (1.2e5 ± 3.4e4 intensity units; p < 0.001) and male SLE mice (5.1e5 ± 1.6e5 intensity units; p < 0.001). Both female and male SLE mice were hypertensive at 35 weeks: blood pressure was higher in female SLE than female controls (152 ± 5 vs. 126 ± 3 mmHg; n=6‐8; p=0.003) and in male SLE compared to male controls (152 ± 4 vs. 136 ± 4 mmHg; n=6‐11; p=0.041).ConclusionThese data indicate that increased expression of renal TLR7 and TNF‐α is associated with renal injury and hypertension in female SLE mice. In addition, these data suggest a potential sex difference in the pathogenesis of SLE in males. Therapeutic strategies targeting the TLR7 molecular pathway should be further investigated in both female and male lupus nephritis.